Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Mauricio Moreno

Concepts (285)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Free Tissue Flaps
14
2025
63
7.440
Why?
Head and Neck Neoplasms
15
2025
288
6.430
Why?
Mandibular Reconstruction
3
2024
15
1.920
Why?
Neck Dissection
6
2021
30
1.780
Why?
Retrospective Studies
30
2025
6274
1.680
Why?
Length of Stay
4
2023
631
1.640
Why?
Neck
4
2021
100
1.470
Why?
Carcinoma, Squamous Cell
3
2024
326
1.460
Why?
Laryngectomy
3
2024
27
1.420
Why?
Middle Aged
35
2025
12579
1.310
Why?
Neoplasm Recurrence, Local
6
2024
622
1.300
Why?
Postoperative Complications
10
2025
1030
1.190
Why?
Aged
28
2025
9738
1.110
Why?
Salvage Therapy
2
2024
137
1.040
Why?
Aged, 80 and over
16
2025
3233
1.020
Why?
Male
36
2025
25866
0.980
Why?
Critical Pathways
3
2023
36
0.980
Why?
Female
38
2025
27053
0.960
Why?
Pharyngectomy
1
2024
2
0.910
Why?
Time-to-Treatment
2
2025
73
0.900
Why?
Skull
1
2024
77
0.880
Why?
Scalp
1
2024
40
0.880
Why?
Laryngeal Neoplasms
1
2024
43
0.880
Why?
Mandible
2
2024
27
0.870
Why?
Skin Neoplasms
4
2024
492
0.860
Why?
Humans
51
2025
50419
0.860
Why?
Operative Time
1
2023
70
0.850
Why?
Surgery, Computer-Assisted
1
2023
53
0.830
Why?
Thyroidectomy
3
2021
60
0.820
Why?
Treatment Outcome
19
2025
5265
0.810
Why?
Head
2
2021
72
0.790
Why?
Adult
24
2025
13561
0.760
Why?
Intraoperative Complications
2
2021
112
0.750
Why?
Intraoperative Care
1
2021
52
0.750
Why?
Chylothorax
1
2021
15
0.720
Why?
Hypotension
1
2021
63
0.710
Why?
Vasoconstrictor Agents
1
2021
83
0.710
Why?
Venous Thrombosis
1
2021
86
0.690
Why?
Morbidity
1
2021
130
0.690
Why?
Paranasal Sinus Neoplasms
2
2010
20
0.670
Why?
Naproxen
1
2019
7
0.660
Why?
Thyroid Neoplasms
2
2012
109
0.660
Why?
Orthognathic Surgical Procedures
1
2019
2
0.660
Why?
Reoperation
1
2021
461
0.640
Why?
Edema
1
2019
69
0.620
Why?
Health Status Indicators
1
2019
83
0.610
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2019
120
0.600
Why?
Health Resources
1
2019
74
0.590
Why?
Academic Medical Centers
2
2019
147
0.560
Why?
Radiotherapy, Adjuvant
5
2025
63
0.560
Why?
Thigh
2
2015
33
0.540
Why?
Melanoma
2
2010
278
0.530
Why?
Surgical Flaps
2
2023
110
0.510
Why?
Patient Discharge
2
2019
318
0.500
Why?
Databases, Factual
2
2019
676
0.480
Why?
Carcinoma, Papillary
2
2012
47
0.440
Why?
Parathyroidectomy
2
2012
46
0.440
Why?
Video-Assisted Surgery
1
2013
1
0.420
Why?
Tissue and Organ Harvesting
1
2013
24
0.420
Why?
Soft Tissue Injuries
1
2013
17
0.420
Why?
Neck Injuries
1
2013
21
0.410
Why?
Endoscopy
1
2013
117
0.390
Why?
Prognosis
4
2024
1974
0.380
Why?
Speech, Esophageal
1
2010
1
0.360
Why?
Graft Survival
3
2025
160
0.350
Why?
Combined Modality Therapy
3
2024
640
0.350
Why?
Palatal Obturators
1
2010
1
0.350
Why?
Maxilla
1
2010
14
0.350
Why?
Parathyroid Neoplasms
1
2010
28
0.350
Why?
Neoplasm Staging
4
2024
738
0.350
Why?
Nose Neoplasms
1
2010
3
0.340
Why?
Carcinoma, Merkel Cell
3
2016
40
0.340
Why?
Nasal Mucosa
1
2010
19
0.330
Why?
Adolescent
9
2019
6453
0.330
Why?
Preoperative Care
1
2011
170
0.320
Why?
Adenoma
1
2010
113
0.320
Why?
Follow-Up Studies
6
2023
2231
0.310
Why?
Young Adult
7
2019
4075
0.300
Why?
Deglutition
2
2024
43
0.300
Why?
Fibula
2
2024
23
0.270
Why?
Colitis, Ulcerative
2
2018
55
0.270
Why?
Crohn Disease
2
2018
93
0.260
Why?
Pain, Postoperative
3
2022
163
0.240
Why?
Osteoradionecrosis
1
2024
6
0.230
Why?
Mandibular Diseases
1
2024
11
0.230
Why?
Comorbidity
2
2019
621
0.230
Why?
Adenocarcinoma
2
2023
396
0.230
Why?
TOR Serine-Threonine Kinases
2
2016
76
0.230
Why?
Pharyngeal Diseases
1
2024
12
0.230
Why?
Cutaneous Fistula
1
2024
14
0.220
Why?
Oropharyngeal Neoplasms
1
2024
19
0.220
Why?
Physical Examination
1
2024
94
0.220
Why?
Adenoma, Pleomorphic
1
2023
3
0.220
Why?
Paranasal Sinuses
1
2023
16
0.220
Why?
Salivary Gland Neoplasms
1
2023
7
0.220
Why?
Carcinoma, Ductal
1
2023
7
0.210
Why?
Scapula
1
2023
16
0.210
Why?
Forearm
1
2023
28
0.210
Why?
Sinusitis
1
2023
42
0.210
Why?
Enteral Nutrition
1
2024
149
0.210
Why?
Deglutition Disorders
1
2024
77
0.210
Why?
Ambulatory Care Facilities
1
2023
121
0.210
Why?
Tramadol
1
2022
30
0.200
Why?
Sensitivity and Specificity
1
2024
855
0.190
Why?
Tomography, X-Ray Computed
2
2024
1163
0.190
Why?
Ambulatory Care
1
2023
243
0.190
Why?
Microsurgery
1
2021
30
0.190
Why?
Recurrent Laryngeal Nerve Injuries
1
2021
6
0.190
Why?
Anastomosis, Surgical
1
2021
65
0.190
Why?
Infusions, Intravenous
1
2021
212
0.180
Why?
Gastrointestinal Agents
2
2018
35
0.180
Why?
Cohort Studies
2
2019
1451
0.180
Why?
Indocyanine Green
2
2011
34
0.180
Why?
Drug Administration Schedule
1
2021
373
0.180
Why?
Robotics
1
2021
41
0.180
Why?
Laser Therapy
2
2011
83
0.180
Why?
Health Services Accessibility
1
2025
426
0.170
Why?
Reproducibility of Results
4
2023
1181
0.170
Why?
Odds Ratio
1
2021
550
0.170
Why?
Prospective Studies
5
2024
2378
0.170
Why?
Acetaminophen
1
2022
276
0.170
Why?
Ultrasonography
2
2012
434
0.160
Why?
Analgesics, Opioid
2
2022
577
0.150
Why?
Drug Monitoring
1
2018
81
0.150
Why?
Hospital Costs
1
2019
71
0.150
Why?
Postoperative Care
1
2019
103
0.150
Why?
Arkansas
2
2025
1974
0.140
Why?
Graft Rejection
1
2019
173
0.140
Why?
Analysis of Variance
1
2019
549
0.140
Why?
Heart Defects, Congenital
1
2023
603
0.140
Why?
Patient Readmission
1
2019
229
0.130
Why?
Antibodies, Monoclonal, Humanized
1
2018
224
0.130
Why?
Benzoxazoles
1
2016
11
0.130
Why?
United States
2
2019
5005
0.130
Why?
Predictive Value of Tests
2
2024
924
0.120
Why?
Proto-Oncogene Proteins c-myb
1
2015
8
0.120
Why?
Cell Proliferation
2
2016
980
0.120
Why?
Pyrimidines
1
2016
187
0.110
Why?
Regression Analysis
2
2012
376
0.110
Why?
Child
4
2018
6931
0.110
Why?
Nuclear Proteins
1
2015
235
0.110
Why?
Apoptosis
2
2016
1092
0.110
Why?
Quality of Life
1
2019
850
0.100
Why?
Skin Transplantation
1
2013
43
0.100
Why?
Osteocalcin
1
2012
43
0.100
Why?
Survival
1
2012
11
0.100
Why?
Equipment Design
1
2013
290
0.100
Why?
Hyperparathyroidism, Primary
1
2012
36
0.100
Why?
Recurrence
2
2012
657
0.100
Why?
Iodine Radioisotopes
1
2012
35
0.100
Why?
Leukoplakia, Oral
1
2011
6
0.090
Why?
Aminolevulinic Acid
1
2011
8
0.090
Why?
Lasers, Dye
1
2011
10
0.090
Why?
Decision Support Techniques
1
2012
70
0.090
Why?
Epigenesis, Genetic
1
2015
371
0.090
Why?
Hospital Mortality
1
2014
411
0.090
Why?
Photosensitizing Agents
1
2011
19
0.090
Why?
Thyroid Gland
2
2022
75
0.090
Why?
Dose-Response Relationship, Radiation
1
2012
183
0.090
Why?
Transcription Factors
1
2015
561
0.090
Why?
Infrared Rays
1
2011
25
0.090
Why?
Photochemotherapy
1
2011
33
0.090
Why?
Biopsy, Fine-Needle
1
2012
108
0.090
Why?
Parathyroid Hormone
1
2012
149
0.090
Why?
Fascia
1
2010
6
0.090
Why?
Lymph Node Excision
1
2012
131
0.090
Why?
Laser Coagulation
1
2011
26
0.090
Why?
Coloring Agents
1
2011
67
0.090
Why?
Tongue Neoplasms
1
2010
11
0.090
Why?
Carcinoma
1
2012
137
0.090
Why?
Kaplan-Meier Estimate
1
2012
462
0.090
Why?
Speech Intelligibility
1
2010
14
0.090
Why?
Mammary Neoplasms, Experimental
1
2011
121
0.090
Why?
Veins
1
2011
73
0.090
Why?
Survival Analysis
1
2012
658
0.080
Why?
Vascular Diseases
1
2011
73
0.080
Why?
Disease-Free Survival
1
2011
439
0.080
Why?
Lymph Nodes
1
2012
256
0.080
Why?
Tracheostomy
1
2010
71
0.080
Why?
Quality Indicators, Health Care
1
2010
87
0.080
Why?
Risk Assessment
1
2014
1268
0.080
Why?
Guideline Adherence
1
2010
136
0.080
Why?
Positron-Emission Tomography
1
2010
290
0.070
Why?
Survival Rate
1
2010
906
0.070
Why?
Models, Biological
1
2011
717
0.070
Why?
Pneumothorax, Artificial
1
2007
1
0.070
Why?
Urologic Surgical Procedures
1
2007
27
0.070
Why?
Severity of Illness Index
3
2018
976
0.070
Why?
Disease Progression
1
2010
825
0.070
Why?
Diaphragm
1
2007
31
0.070
Why?
Atrioventricular Node
1
2006
4
0.070
Why?
Tachycardia, Ectopic Atrial
1
2006
3
0.070
Why?
Cryosurgery
1
2006
36
0.060
Why?
Pilot Projects
2
2022
694
0.060
Why?
Azepines
2
2016
19
0.060
Why?
Risk Factors
1
2014
3712
0.060
Why?
Pulmonary Veins
1
2005
41
0.060
Why?
Laparoscopy
1
2007
172
0.060
Why?
Xenograft Model Antitumor Assays
2
2016
210
0.060
Why?
Triazoles
2
2016
113
0.060
Why?
Fluoroscopy
1
2024
48
0.060
Why?
Video Recording
1
2024
84
0.050
Why?
Salivary Ducts
1
2023
3
0.050
Why?
Parotid Gland
1
2023
8
0.050
Why?
Ubiquitin Thiolesterase
1
2023
17
0.050
Why?
Facial Bones
1
2023
17
0.050
Why?
Atrial Fibrillation
1
2005
188
0.050
Why?
Ibuprofen
1
2022
20
0.050
Why?
Tumor Suppressor Proteins
1
2023
127
0.050
Why?
Recurrent Laryngeal Nerve
1
2021
12
0.050
Why?
Laryngeal Nerves
1
2021
15
0.050
Why?
Glossectomy
1
2021
5
0.050
Why?
Tongue
1
2021
40
0.040
Why?
Arteries
1
2021
91
0.040
Why?
Immunohistochemistry
1
2023
955
0.040
Why?
Cell Line, Tumor
2
2015
1393
0.040
Why?
Mice
3
2016
5659
0.040
Why?
Pain Management
1
2021
180
0.040
Why?
Statistics, Nonparametric
1
2018
189
0.040
Why?
Enzyme-Linked Immunosorbent Assay
1
2018
227
0.040
Why?
Reference Values
1
2018
302
0.040
Why?
Colonoscopy
1
2018
100
0.040
Why?
Immunotherapy
1
2018
234
0.030
Why?
Chile
1
2016
4
0.030
Why?
Enterocolitis, Pseudomembranous
1
2016
24
0.030
Why?
Digestive System Surgical Procedures
1
2016
32
0.030
Why?
Age of Onset
1
2016
109
0.030
Why?
Age Distribution
1
2016
172
0.030
Why?
Mice, Inbred NOD
1
2016
89
0.030
Why?
Immunoenzyme Techniques
1
2016
140
0.030
Why?
Drug Synergism
1
2016
149
0.030
Why?
Mice, SCID
1
2016
171
0.030
Why?
Jumonji Domain-Containing Histone Demethylases
1
2015
17
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2016
179
0.030
Why?
Animals
3
2016
13063
0.030
Why?
Tumor Cells, Cultured
1
2016
453
0.030
Why?
Enhancer Elements, Genetic
1
2015
57
0.030
Why?
Acetylation
1
2015
94
0.030
Why?
Drug Therapy, Combination
1
2016
387
0.030
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2016
568
0.030
Why?
Blotting, Western
1
2016
575
0.030
Why?
Immunosuppressive Agents
1
2016
227
0.030
Why?
Chromatin
1
2015
133
0.030
Why?
Neoplasm Metastasis
1
2015
230
0.030
Why?
Cell Cycle Proteins
1
2015
163
0.030
Why?
Referral and Consultation
1
2016
287
0.030
Why?
Amino Acid Chloromethyl Ketones
1
2013
10
0.030
Why?
Phagosomes
1
2013
19
0.030
Why?
Tissue Fixation
1
2013
35
0.030
Why?
Paraffin Embedding
1
2013
51
0.030
Why?
Formaldehyde
1
2013
49
0.030
Why?
Caspases
1
2013
103
0.030
Why?
Protein Binding
1
2015
648
0.030
Why?
Enzyme Activation
1
2013
268
0.030
Why?
Registries
1
2016
565
0.030
Why?
Promoter Regions, Genetic
1
2015
455
0.030
Why?
RNA, Messenger
1
2016
1085
0.020
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2018
997
0.020
Why?
Preoperative Period
1
2012
46
0.020
Why?
Up-Regulation
1
2013
446
0.020
Why?
Protein Kinase Inhibitors
1
2013
204
0.020
Why?
Cell Survival
1
2013
587
0.020
Why?
Postoperative Period
1
2012
171
0.020
Why?
Hospitalization
1
2016
677
0.020
Why?
Administration, Topical
1
2011
67
0.020
Why?
Injections, Intravenous
1
2011
137
0.020
Why?
Gene Expression Regulation, Neoplastic
1
2015
831
0.020
Why?
Multivariate Analysis
1
2012
583
0.020
Why?
Cancer Care Facilities
1
2010
18
0.020
Why?
Lasers
1
2011
106
0.020
Why?
Leg
1
2011
123
0.020
Why?
Time Factors
1
2016
2933
0.020
Why?
Biopsy
1
2011
588
0.020
Why?
Quality Assurance, Health Care
1
2010
149
0.020
Why?
Dose-Response Relationship, Drug
1
2011
1369
0.020
Why?
Child, Preschool
1
2016
3953
0.020
Why?
Carbon Dioxide
1
2007
94
0.020
Why?
Secondary Prevention
1
2006
80
0.020
Why?
Atrial Function
1
2005
7
0.020
Why?
Electrocardiography, Ambulatory
1
2005
23
0.020
Why?
Angiography
1
2005
128
0.010
Why?
Heart Rate
1
2006
304
0.010
Why?
Electrocardiography
1
2006
266
0.010
Why?
Catheter Ablation
1
2005
120
0.010
Why?
Logistic Models
1
2005
901
0.010
Why?
Moreno's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description